by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
The scientific community’s interest in PE-22-28 (Spadin Analog PE-22-28) has grown steadily over the past decade. Composed of 7 amino acids, this peptide has demonstrated notable effects in preclinical models related to TREK-1 inhibitor and antidepressant. Here,...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Among the many peptides under active investigation, Dihexa stands out for its unique properties and versatile research applications. Originally studied for its effects on synaptogenesis, researchers have since discovered connections to memory enhancement, Alzheimer...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Semax (Semax Heptapeptide) has emerged as one of the most studied peptides in modern biomedical research. With its 7 amino acids structure, this compound has attracted attention from researchers worldwide for its potential roles in BDNF increase and neuroprotection....
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
In the ever-expanding landscape of peptide research, Selank occupies a notable position. This 7 amino acids compound has been the subject of numerous studies investigating its role in immune support and BDNF modulation. This article provides a detailed overview of...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Research into PE-22-28 represents a fascinating intersection of molecular biology, pharmacology, and translational science. This 7 amino acids compound has shown promise in areas ranging from cognitive function to TREK-1 inhibitor, making it a subject of considerable...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
The scientific community’s interest in Dihexa (Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)) has grown steadily over the past decade. Composed of modified hexapeptide, this peptide has demonstrated notable effects in preclinical models related to HGF...
